Data de publicació electrònica: 08-04-2022Sex or gender differences in the risk of Alzheimer's disease and related dementias (ADRD) differ by world region, suggesting that there are potentially modifiable risk factors for intervention. However, few epidemiological or clinical ADRD studies examine sex differences; even fewer evaluate gender in the context of ADRD risk. The goals of this perspective are to: (1) provide definitions of gender, biologic sex, and sexual orientation. and the limitations of examining these as binary variables; (2) provide an overview of what is known with regard to sex and gender differences in the risk, prevention, and diagnosis of ADRD; and (3) discuss these sex and gender differences from a global, worldwide per...
Research indicates that after advanced age, the major risk factor for late-onset Alzheimer's disease...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting cognition, daily func...
Sex differences in Alzheimer’s disease (AD) biology and progression are not yet fully characterized....
Sex or gender differences in the risk of Alzheimer's disease and related dementias (ADRD) differ by ...
Sex or gender differences in the risk of Alzheimer\u27s disease and related dementias (ADRD) differ ...
Alzheimer's disease (AD) is characterized by high heterogeneity in disease manifestation, progressio...
Alzheimer disease (AD) is characterized by wide heterogeneity in cognitive and behavioural syndromes...
Alzheimer disease (AD) is characterized by wide heterogeneity in cognitive and behavioural syndromes...
Neurodegenerative diseases (ND) are among the leading causes of disability and mortality. Considerab...
Neurodegenerative diseases (ND) are among the leading causes of disability and mortality. Considerab...
Neurodegenerative diseases (ND) are among the leading causes of disability and mortality. Considerab...
Women represent (2)/(3) of the cases of Alzheimers disease (AD). Current research has focused on dif...
Background. Actually, there are about 5.2 million people with Alzheimer's dementia (AD) in the USA, ...
IntroductionSex differences in dementia risk, and risk factor (RF) associations with dementia, remai...
Prevalence studies on dementia generally show a higher risk in women than in men. American studies r...
Research indicates that after advanced age, the major risk factor for late-onset Alzheimer's disease...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting cognition, daily func...
Sex differences in Alzheimer’s disease (AD) biology and progression are not yet fully characterized....
Sex or gender differences in the risk of Alzheimer's disease and related dementias (ADRD) differ by ...
Sex or gender differences in the risk of Alzheimer\u27s disease and related dementias (ADRD) differ ...
Alzheimer's disease (AD) is characterized by high heterogeneity in disease manifestation, progressio...
Alzheimer disease (AD) is characterized by wide heterogeneity in cognitive and behavioural syndromes...
Alzheimer disease (AD) is characterized by wide heterogeneity in cognitive and behavioural syndromes...
Neurodegenerative diseases (ND) are among the leading causes of disability and mortality. Considerab...
Neurodegenerative diseases (ND) are among the leading causes of disability and mortality. Considerab...
Neurodegenerative diseases (ND) are among the leading causes of disability and mortality. Considerab...
Women represent (2)/(3) of the cases of Alzheimers disease (AD). Current research has focused on dif...
Background. Actually, there are about 5.2 million people with Alzheimer's dementia (AD) in the USA, ...
IntroductionSex differences in dementia risk, and risk factor (RF) associations with dementia, remai...
Prevalence studies on dementia generally show a higher risk in women than in men. American studies r...
Research indicates that after advanced age, the major risk factor for late-onset Alzheimer's disease...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting cognition, daily func...
Sex differences in Alzheimer’s disease (AD) biology and progression are not yet fully characterized....